Welcome!

News Feed Item

Physician-based Point of Care Diagnostics: Products, Players and Outlook to 2017

NEW YORK, Jan. 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Physician-based Point of Care Diagnostics: Products, Players and Outlook to 2017

http://www.reportlinker.com/p01081137/Physician-based-Point-of-Care-Diagnostics-Products-Players-and-Outlook-to-2017 .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The market for Point-of-Care (POC) diagnostic products used in the physician's surgery was worth approximately US$1.7 billion in 2011 with sectors such as cholesterol testing and tumour markers making the best continued growth in the year. All sectors will see sustained growth over the medium term, with the total addressable market for products that can be potentially used in a physician's office forging ahead to be valued at over US$6.1 billion by 2017.

In the physician's office, POC diagnostics can play a key role in the diagnosis and ongoing monitoring of acute and chronic illnesses, the detection of some types of cancer, the monitoring of patients on anticoagulation drugs, and for general blood and urine testing. It can also play an important role in enabling preventative medicine, which is intended to help curb the increasing incidence of chronic conditions such as diabetes and cardiovascular disease through early detection and identifying patients with risk factors that mean they are likely to develop such conditions in the future.

The benefits for clinicians, patients and health payers are clear. Physician-based testing provides rapid POC diagnosis and faster medical intervention. Healthcare providers are looking for new ways of improving patient outcomes, which in turn reduces the need for more expensive patient care, medications and hospital stays, as well as reducing costs and managing a larger number of patients without increasing staffing levels or numbers of hospital beds.

Challenges remain...

There are several key challenges in the market. Currently, many physicians' offices do not have budgets for in-house diagnostic testing and healthcare funding needs to change in order to provide incentives for doctors to use the products. For this to happen, healthcare providers need evidence that POC diagnostics provide benefits in terms of clinical-usefulness, convenience and cost in order to adopt them. In addition, concerns have also been raised about the accuracy of some POC tests used to diagnose conditions such as influenza. For infectious disease testing, the ongoing development of POC PCR and DNA-based systems is expected to improve on currently-available products. These devices could represent a significant market opportunity for manufacturers, should they be able to reduce the testing time and price point of the products to something suitable for and attractive to physicians. This new January 2013 report delivers a complete analysis

This new 178-page highly-detailed report Physician-based Point-of-Care Diagnostics: Products, Players and Outlook to 2017 provides executives with a complete understanding of the issues which are shaping the market and how they will affect its commercial and clinical development. This is Volume 3 of a 4-Volume study of the whole POC IVD sector to be published late 2012/early 2013. Table of Contents

MARKET OVERVIEW ..1EXECUTIVE SUMMARY ......1

INTRODUCTION ....2

Physician's Office POC Testing ....2The Role of POC Testing in a Physician's Office ....3Regulatory and Reimbursement Environment ....4CLIA Waiver .4

CURRENT MARKET DYNAMICS ......6

Fig.1: POC Diagnostics in Relation to the IVD Market, 2011 .6Fig.2: Percentage of POC Diagnostics Market by Product, 2011 .7Regional Perspective ....7Fig.3: Professional POC Diagnostics Market by Region, 2011 .....8Physician's Office POC Testing Market .....8Addressable Markets for Physician's Office POC Testing, 2007-2011 (US$ million) .....10Fig.4: Addressable Markets for Physician's Office POC Testing, 2011 .....10Fig.5: Physician's Office POC Testing Market, 2011 ......11

GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES .12

POC Diagnostics and the Economy . 12The Burden of Chronic Disease and Preventative Medicine . 12Clinical Utility and Accuracy ..... 14POC Diagnostics as a Disruptive Technology ...... 14Emerging Technologies ..... 15Summary: Market Drivers, Restraints and Opportunities 16

COMPETITIVE LANDSCAPE ....17

Market Leaders for Physician's Office POC Testing Products ....17Select POC Diagnostics Companies' Sales, 2007-2011 (US$ million) ......17Merger and Acquisition Activity ..... 17Key POC Diagnostics Mergers and Acquisitions, 2008-2011 ....18

FUTURE MARKET PROSPECTS ......20

Addressable Markets for Physician's Office POC Testing, 2011-2017E (US$ million) ...21Growth in the Addressable Markets for Physician's Office POC Testing, 2008-2017E (%) .21Physician's Office POC Testing Market, 2011-2012E (US$ million) ...21Fig.6: Physician's Office POC Testing Market, 2012(E) .22

PHYSICIAN'S OFFICE POC PRODUCTS AND TECHNOLOGIES ..23

POC HBA1C TESTING .23

Diabetes Prevalence and Burden to the Healthcare System 23

Fig.7: Diabetes Prevalence by Geographic Region, 2011-2030 .23

Diabetes Prevalence for the Top 10 Countries, 2011-2030 (million) 24

Diabetes Management and the Role of HbA1c Testing ...25

POC HbA1c Testing Market 27

Fig.8: Global POC HbA1c Testing Market, 2007-2017E (US$ million) ......27

POC HbA1c Products ....27

ApexBio's A1C Express ....27

Alere/Axis-Shield's Afinion HbA1c and NycoCard HbA1c Tests ...27

Bayer's A1CNow Products .....28

Bio-Rad's in2it A1C Analyser 28

DiaSys Diagnostic Systems' InnovaStar .....28

Ceragem Medisys' HbA1c Analysers ...29

EKF Diagnostics' Quo-Lab, Quo-Test and Biosen HbA1c Analysers ...29

Infopia's Easy/Clover A1c 29

Siemens' DCA Vantage Analyser .29

Tosoh Bioscience's G8 HPLC Analyzer .30

In Development ......30

POC CHOLESTEROL TESTING ...... 32

Cholesterol Testing and Preventative Medicine .32

POC Cholesterol Testing Market Dynamics ..33

Fig.9: Global POC Cholesterol Testing Market, 2007-2017E (US$ million) ....34

Fig:10: POC Cholesterol Testing Market by End User, 2011 ......34

Available Products ......35

Alere's Cholestech LDX System .....35

Akers Biosciences' Tri-Cholesterol Check ..35

Chematics' Chemcard Cholesterol Test ......35

General Life Biotechnology's BeneCheck LipidEx ST ...35

Infopia's Lipid Pro . 36

Jant Pharmacal's LipidPlus Lipid Profile and Glucose Test System ...... 36

Miraculins' PreVu Point of Care Skin Sterol Test .... 36

Distribution Agreements .....37

Polymer Technology Systems' CardioChek PA 37

Roche's Accutrend Plus .... 38

Syntron Bioresearch's Venture Total Cholesterol Test 38

Products in Development 38

Roche and Panasonic Healthcare .....38

POC COAGULATION TESTING ...... 39

POC Coagulation Testing Market Dynamics 39

Fig.11: Global POC Coagulation Market, 2007-2017E (US$ million) ......40

The Impact of New-Generation Anticoagulants .. 40

Patient Self-Testing and Issues for Doctors .41

CoaguSense's CoaguSense PT/INR Monitoring System ..... 43

Alere's INRatio2 System ... 43

International Technidyne Corporation's ProTime Microcoagulation System 43

Roche's CoaguChek XS .... 43

Professional Use Products 44

Alere's Axis-Shield Products ... 44

Helena Laboratories' Cascade POC System ..... 44

Instrumentation Laboratory's GEM PCL Plus .. 45

Roche's CoaguChek Systems .. 45

CoaguChek XS Pro .45

CoaguChek XS Plus 45

CoaguChek XS .45

CoaguChek Link ......45

Products in Development 46

Bio-AMD's COAG . 46

Siemens/Universal Biosensors' POC Coagulation Tests ..... 46

POC CLINICAL CHEMISTRY AND HAEMATOLOGY PRODUCTS ...... 47

Multi-Functional POC Clinical Chemistry Analysers .47

Handheld POC Analysers Suitable for Use by Physicians ...47

Abaxis' Piccolo xpress ...47

Abbott's i-STAT System .48

Alere/Axis-Shield's Afinion POC System ...49

Alere/Axis-Shield's NycoCard System 49

Benchtop Systems Suitable for Physician's Laboratories .. 50

Alfa Wassermann's ACE Clinical Chemistry Systems ...50

Arkray's SpotChem Systems ......50

SpotChem Test Strips ....51

Audit Diagnostics' Liqui-Stat System 51

DiaSys Diagnostic Systems' InnovaStar ....51

Horiba's ABX Pentra Clinical Chemistry Analysers 52

Ortho-Clinical Diagnostics' VITROS DT60 II Chemistry System .52

Qualigen's FastPack IP System ....52

Samsung's LABGEO Clinical Chemistry Analysers .52

Tosoh Bioscience's AIA Immunoassay Analysers ..52

POC Haematology and Haemoglobin Analysers 53

POC Haemoglobin Systems .....53

POC Analyser Accuracy ..53

ACON Laboratories' Mission Hb Hemoglobin Testing Systems .54

ApexBio's HemoSmart Haemoglobin Screening System ...54

Audit Diagnostics' Hb-Stat ..54

Ceragem Medisys' CERA-CHEK Hb Plus ....54

EKF Diagnostics' Products ....54

General Life Biotechnology's BeneCheck Hb Hemoglobin Test System 55

OrSense's Glasswing and NBM 200 Systems ..55

Quest Diagnostics' HemoCue Haemoglobin Systems .56

URIT Medical's URIT-12 Hemoglobin Meter ....57

POC C-REACTIVE PROTEIN DIAGNOSTICS ...... 58

Abaxis' MetLyte Plus CRP and BioChemistry Panel Plus .58

Alere/Axis-Shield ..59

bioMérieux bioNexia CRP Test .59

LifeAssays' CRP .....59

Medix Biochemica's Actim CRP 59

Orion Diagnostica's QuikRead and QuikRead go Systems ....59

POC PHYSICIAN'S OFFICE INFECTIOUS DISEASE TESTS ...60

Current Market Dynamics ..61

Fig.12: Market for POC Infectious Disease Tests used in a Physician's Office, 2007-2017E (US$ million) 61

POC Influenza Testing .61

Performance and Use of Rapid Influenza Tests in the US .. 62

CDC Recommendations 62

CDC: Influenza Prevalence and Test Accuracy ......63

POC Influenza Testing Market 63

Future Prospects .. 64

CLIA-Waived Flu Detection Products .. 64

Alere's Influenza Tests ..64

Becton Dickinson's BD Veritor System ......64

Quidel's Sofia Analyzer and Sofia Influenza A+B Fluorescent Immunoassays ....65

Quidel's QuickVue Influenza Tests .....65

SA Scientific's SAS FluAlert .65

Other POC Flu Detection Products ...... 65

bioMérieux' bioNexia Influenza A+B Tests ....66

IQuum's Liat Influenza A/B Assay and the Liat Analyzer ...66

Jant Pharmacal's Accutest Flu Test ....67

Medix Biochemica's Actim Influenza A&B ......67

Meridian Bioscience's TRU FLU ...67

Mizuho Medy's Quick Chaser Flu A,B .67

OraSure Technologies' OraSure QuickFlu Rapid Flu A+B Test ...67

Princeton BioMeditech's BioSign Flu A+B .....67

Response Biomedical's Influenza A+B Test ....68

Sekisui Diagnostics' OSOM Influenza A & B Test ...68

Products in Development 68

Chembio's DPP Influenza Tests ...68

Cepheid's GeneXpert ....69

Lucigen's Nucleic Acid-Based POC Test ....69

Respiratory Syncytial Virus ......69

Quidel's Sofia RSV Fluorescent Immunoassay .70

Quidel's QuickVue RSV 10 .71

Response Biomedical's RSV Test ....71

Other Respiratory Tests .....71

Ani Biotech's Biocard Chlamydia Pneumoniae IgM Test .....71

GenBio's ImmunoFLOW Mycoplasma IgM Test ..... 72

Group A Streptococcus Tests ....72

Currently-Available POC Strep A Tests ...73

Quidel's Sofia Strep A Fluorescent Immunoassay 73

H. pylori Tests .74

Currently-Available H. pylori Tests . 74

Exalenz Bioscience's BreathID System 75

Otsuka America Pharmaceutical's BreathTek UBT .75

Mononucleosis Tests ...76

Currently-Available POC Mono Tests .....76

Rotavirus and Adenoviral Enteritis Tests .....76

Ani Biotech's Biocard Tests ......76

Meridian Bioscience ImmunoCard STAT! Rotavirus ..... 77

Nicox/Rapid Pathogen Screening's AdenoPlus .... 77

Orion Diagnostica's Diarlex, Rotalex and Adenolex Tests . 77

Women's Heath Diagnostics .....77

Ani Biotech's Biocard Candida and Trichomonas Tests ...... 77

Gryphus Diagnostics' BVBLUE ...... 77

Quidel's QuickView Chlamydia Test ... 78

RunBio Biotech's Tests ...... 78

Savyon Diagnostics' SavvyCheck . 78

POC TUMOUR MARKER TESTING ...... 79

Fig.13: Global POC Tumour Markers Market, 2007-2017E (US$ million) ......79

Prostate Specific Antigen Tests 80

Available Tests 81

Mediwatch's PSAwatch 81

OPKO Health's OPKO Diagnostics Platform ....82

Occult Blood Testing ...82

ACON Laboratories' Mission FOB Reagent Strips . 83

Aerscher Diagnostics' HemaPrompt .. 83

Alere's Tests .... 83

Beckman Coulter's Hemoccult Tests .. 83

Biomerica's EZ Detect 83

bioMérieux' bioNexia FOBplus ..... 84

Helena Laboratories' ColoCare ..... 84

Immunostics' Hema-Screen ... 84

Orion Diagnostica's QuikRead System and Orion Q-flow FOB ...... 84

Princeton BioMeditech's BioSign iFOBTest ..... 84

Quest Diagnostics' InSure Quik F I T ... 85

Quidel's QuickVue iFOB ... 85

Other Available FOB Tests ...... 86

Gastric Occult Blood Tests 86

CEA Testing .....87

Alpha Fetoprotein Testing .87

Bladder Cancer Testing ......87

Alere's Matritech NMP22 BladderChek Test .... 88

bioMérieux' bioNexia BTA ...... 88

Mediwatch's Bladderwatch BTA Test .. 88

Novel Products in Development .....88

Bioscience Ventures/ Serascience's POC Myeloma Test ..... 88

Guided Therapeutics' Non-Invasive Cancer Diagnostic Products 88

LuViva Advanced Cervical Scan .88

Oesophageal and Other Cancer Detection ......89

Infopia's Cancer Diagnosing Sensor ... 90

POC URINALYSIS TESTING .... 91

Fig.9: Global POC Urinalysis Market, 2007-2017E (US$ million) .....92

Key Urine Analysis Test Strips ..92

Product Highlights ......92

77 Elektronika's DocUReader 2 and DocuReader 2 Pro ......92

ACON Laboratories' Mission Products .93

Arkray's Products ..93

PocketChem UA ......93

AUTION ELEVEN ......93

DiaScreen 50 Urine Chemistry Analyser and DiaScreen Reagent Strips 93

Roche's Products ...93

Urisys 1100 Urine Analyser ..93

Chemstrip Criterion II Analyzer ..94

Chemstrips/Combur-Test Strips .94

Siemens' Products 94

Clinitek Status+ .....94

Clinitek Status Connect .94

Multistix10 SG Reagent Strips ....94

RAPIDComm Data Management and Connectivity Solution ....95

Microalbumin Testing .95

Axis-Shield's Afinion ACR Test 95

Biomerica's Fortel Microalbumin Screening-OTC Test 96

Orion Diagnostica's QuikRead U-ALB . 96

Quest Diagnostics' HemoCue Albumin 201 System .... 96

Sekisui Diagnostics' OSOM ImmunoDip Urinary Albumin Test ..... 96

Siemens' Clinitek Microalbumin Strips ..... 96

OTHER PRODUCTS ... 97

Alere Heart Check System for Heart Failure Monitoring 97

Liver Function Testing .97

Exalenz Bioscience's BreathID System ...... 97

BreathID Methacetin Breath Test ......98

Infopia's Pioneer POCT Liver Test Sensor .. 98

Thyroid Tests ..98

Jant Pharmacal's Accutest TSH .... 98

Screening Devices Canada's ThyroChek ... 98

Ani Biotech's Biocard Coeliac Tests .99

Rapid Pathogen Screening's InflammaDry ..99

Products in Development ...... 100

Akers Biosciences' BreathPulmo Health Check and Breath Asthma Check 100

POC Breath Asthma Check .100

EMERGING TECHNOLOGIES ...... 101

Applied Nanodetectors' Sensor Array Platform ......101

Ativa Medical's POC System ....101

Bio-AMD's MPR ...102

Biosensia's RapiPlex .102

Cepheid's GeneXpert 103

MagnaBioSciences' MICT On-Site System ..104

Molecular Vision .104

MycroLab 105

OPKO Health's OPKO Diagnostics Platform ......106

pes diagnosesysteme' respons IQ .106

Philips' Minicare .107

Radisens Diagnostics' POC Platform ...108

T2 Biosystems' T2Dx System ..108

T2Hemostasis Assay 109

Tyrian Diagnostics' DiagnostIQ ....110

MANUFACTURERS .111

COMPANY DIRECTORY ..111SELECTED COMPANY PROFILES .117

Abaxis .....117

Piccolo xpress 117

Financial Performance ....118

Abaxis Operating Results, 2007-2012 (US$ million) . 118

Latest Results 118

Akers Biosciences ......119

Recent Key Events .... 119

Current Products 120

PIFA Heparin/PF4 and PIFA PLUSS Rapid Assays 120

Tri-Cholesterol Check ..120

Research and Development ..121

BreathPulmo Health Check ...... 121

POC Breath Asthma Check . 121

Current Alliances and Distribution Agreements ..121

PULSE Health . 121

Al Tadawi Medical Equip/PharmaNova Medical Equipment ..122

Fisher HealthCare .122

US Government Service Administration Schedule Contract ...122

Financial Performance ... 122

Akers Biosciences Operating Results, 2007-2011 (US$ thousands) ..... 123

Fig.15: Percentage of Akers' Revenue by Product Type, 2011 123

Alere .124

Recent Key Events .... 124

POC Cardiology Diagnostic Products ...... 125

Alere Heart Check System ..125

Cholestech LDX .....125

INRatio2 System ...125

Axis-Shield POC Products ..... 125

Afinion POC System .... 126

NycoCard 126

Coagulation Products ......127

POC Oncology Products ..127

POC Infectious Disease Tests .127

POC Mergers & Acquisitions . 128

Axis-Shield ....128

Medical Automation Systems' .128

Standard Diagnostics ..128

Assets from Unotech Diagnostics ....128

Mologic, Jinsung Meditech, Biolinker and Long Chain International Corp ..128

Zycare, Medim and Biosyn .129

ACON Laboratories' Rapid Diagnostics Assets .... 129

Matria Healthcare 129

BBI Holdings .129

Other Acquisitions 129

Agreements .130

EKF Diagnostics ....130

Spartan Bioscience ......130

Financial Performance ....131

Alere - Operating Results, 2007-2011 (US$ million) . 132

Fig.16: Percentage of Alere's Revenue by Segment, 2011 ...... 132

Fig.17: Percentage of Alere's Revenue by Region, 2011 .. 132

Alere Professional Diagnostics: Operating Results, 2007-2011 (US$ million) ... 133

Alere Professional Diagnostics: Net Sales & Services Revenue, 2007-2011 (US$ million) ...... 133

Fig.18: Alere Professional Diagnostics: Net Sales & Services Revenue by Product, 2011 . 133

Latest Results ...... 133

Axis Shield - Financial Performance 134

Fig.19: Axis-Shield Revenue by Business Unit, 2010 . 135

Fig.20: Axis-Shield Revenue by Region, 2010 .... 135

Axis-Shield - POC Segment Operating Results, 2006-2010 (£ million) ...... 135

Axis-Shield - POC Sales by Product Line, 2006-2010 (£ million) .. 136

Fig.21: Axis-Shield POC Sales by Product, 2010 . 136

Fig.22: Axis-Shield Afinion Sales by Region, 2010 .... 136

Arkray .....137

Recent Key Events .... 137

POC Testing Products .....137

SpotChem EZ Dry Chemistry Analyser .. 137

SpotChem D-Concept .138

SpotChem CL SB-1440 Automatic Blood Cell Counter ......138

PocketChem BA Blood Ammonia Meters .....138

Urinalysis 139

Current Alliances 139

ELITech Group 139

Beckman Coulter (Danaher) ...140

POC Products ...... 140

Hemoccult Tests ..140

Gastroccult .... 141

International Technidyne Corporation ......142

Products . 142

ProTime Coagulation Systems .. 142

Hemochron Whole Blood Coagulation System .. 142

Current Alliances 143

Roche ...... 143

Financial Performance ... 143

International Technidyne Operating Results, 2004-2009 (US$ million) ....144

Fig.23: International Technidyne Revenue, 2000-2010 (US$ million) 144

Orion Diagnostica ......145

QuikRead 101 System ..... 145

QuikRead go 145

Uricult Dipslide Tests ...... 146

Rotaviral and Adenoviral Enteritis Tests . 146

Financial Performance ....147

Orion Diagnostica - Operating Results, 2007-2011 (EUR million) 147

Meridian Bioscience ..148

TRU FLU and TRU RSV ..... 148

ImmunoCard STAT! HpSA H. pylori Test .. 148

ImmunoCard STAT! Rotavirus ..... 148

ImmunoCard STAT! Strep A .. 148

ImmunoCard STAT! MONO ... 148

ImmunoCard STAT! hCG Combo Test 149

Financial Performance ... 149

Meridian Bioscience - Operating Results, 2008-2012 (US$ million) ....149

Meridian Bioscience - Third-Party Sales by Segment, 2008-2012 (US$ million) .....149

Meridian Bioscience - Operating Income by Segment, 2008-2012 (US$ million) ....149

Fig.24: Meridian Bioscience - Revenue by Segment, 2012 ....150

Meridian Bioscience - European Diagnostics Sales by Country, 2006-2011 (US$ million) .....150

Outlook ...150

Quest Diagnostics ......151

HemoCue Products ...151

Haemoglobin Systems 151

HemoCue Albumin 201 System .... .. . 152

HemoCue White Blood Cell Analyzer ..... 152

HemoCue WBC DIFF .... 153

HemoCue Basic Data Management and Connectivity Software ... 153

Enterix Products . 153

InSure Quik F I T Fecal Immunochemical Test ... .. 153

Litigation with EKF Diagnostics .. 154

Financial Performance ... 154

Quest Diagnostics - Operating Results, 2007-2011 (US$ million) 155

Quest Diagnostics - Sales and Earnings by Category, 2007-2011 (US$ million) ...... 155

Fig.25: Quest Diagnostics - Revenue by Division, 2011 .. 155

Latest Results and Outlook 155

Quidel ....157

Recent Key Events .... 157

Sofia Analyzer and the Sofia Influenza A+B Fluorescent Immunoassay 157

QuickVue Rapid Tests ..... 158

QuickVue Influenza Tests ...158

QuickVue Group A Strep Tests ...158

QuickVue RSV Tests .....158

QuickVue+ Infectious Mononucleosis ... 159

QuickVue iFOB ..... 159

QuickVue H. Pylori gII Test . 159

Financial Performance ... 159

Quidel - Operating Results, 2007-2011 (US$ million) .....160

Quidel - Revenue by Product Type, 2008-2011 (US$ million) 160

Fig.26: Quidel - Revenue by Product Type, 2011 ......160

Fig.27: Quidel - Infectious Disease Revenue, 2005-2011 (US$ million) ...... 161

Quidel - Revenue by Region, 2005-2011 (US$ million) .. 161

Fig.28: Quidel - Revenue by Region, 2011 .. 161

Latest Results ...... 162

Roche Diagnostics .....163

Recent Key Events ....163

CoaguChek Systems 164

CoaguChek XS Pro ......164

CoaguChek XS Plus .....164

CoaguChek XS ......164

CoaguChek Link ....164

Urinalysis 165

Urisys 1100 Urine Analyser 165

Chemstrip Criterion II Analyzer 165

Chemstrips/Combur-Test Strips ......165

Current Alliances and Contracts . 165

Panasonic Healthcare .165

Voluntis ...166

Financial Performance ... 166

Roche Diagnostics Operating Results, 2010-2011 (SFr million) ...166

Fig.29: Roche Diagnostics - Revenue by Product Line, 2011 .167

Fig.30: Roche Professional Diagnostics - Revenue by Region, 2011 ....167

Latest Results 167

Sekisui Diagnostics ...168

Point of Care Tests .... 168

OSOM RSV/Adenovirus Rapid Test ..168

OSOM Influenza A & B Test 168

OSOM H. pylori ....168

OSOM Ultra Strep A .....168

OSOM Strep A 169

OSOM Mono ..169

OSOM Trichomonas Rapid Test .169

OSOM BVBLUE Test ......169

OSOM ImmunoDip Urinary Albumin Test .....169

OSOM Pregnancy Tests ......169

Siemens Healthcare ..170

Products ..170

Diabetes Testing - DCA Vantage Analyser ..... 170

Urinlysis Products 171

RAPIDComm Data Management and Connectivity Solution .. 172

Current Alliances and Supply Contracts .. 172

Universal Biosensors ...172

Premier ...173

Roche ......173

Financial Performance ... 173

Latest Results 173

Thermo Fisher Scientific ..174

Sure-Vue Tests ......174

Remel's Xpect Tests ...174

APPENDICES ...175

APPENDIX 1 - LIST OF ABBREVIATIONS . 175APPENDIX 2 - REPORT METHODOLOGY 176

Sources ...176

Market forecasts .177

SELECTED COMPANY PROFILES

• Abaxis

• Akers Biosciences

• Alere

• Arkray

Beckman Coulter (Danaher)

• International Technidyne Corporation

• Orion Diagnostica

• Meridian Bioscience

• Quest Diagnostics

• Quidel

• Roche Diagnostics

• Sekisui Diagnostics

• Siemens Healthcare

• Thermo Fisher Scientific

To order this report:In_Vitro_Diagnostic Industry: Physician-based Point of Care Diagnostics: Products, Players and Outlook to 2017

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smar...
Unsecured IoT devices were used to launch crippling DDOS attacks in October 2016, targeting services such as Twitter, Spotify, and GitHub. Subsequent testimony to Congress about potential attacks on office buildings, schools, and hospitals raised the possibility for the IoT to harm and even kill people. What should be done? Does the government need to intervene? This panel at @ThingExpo New York brings together leading IoT and security experts to discuss this very serious topic.
Internet of @ThingsExpo has announced today that Chris Matthieu has been named tech chair of Internet of @ThingsExpo 2017 New York The 7th Internet of @ThingsExpo will take place on June 6-8, 2017, at the Javits Center in New York City, New York. Chris Matthieu is the co-founder and CTO of Octoblu, a revolutionary real-time IoT platform recently acquired by Citrix. Octoblu connects things, systems, people and clouds to a global mesh network allowing users to automate and control design flo...
"We analyze the video streaming experience. We are gathering the user behavior in real time from the user devices and we analyze how users experience the video streaming," explained Eric Kim, Founder and CEO at Streamlyzer, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events has announced today that Roger Strukhoff has been named conference chair of Cloud Expo and @ThingsExpo 2017 New York. The 20th Cloud Expo and 7th @ThingsExpo will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "The Internet of Things brings trillions of dollars of opportunity to developers and enterprise IT, no matter how you measure it," stated Roger Strukhoff. "More importantly, it leverages the power of devices and the Internet to enable us all to im...
Everyone knows that truly innovative companies learn as they go along, pushing boundaries in response to market changes and demands. What's more of a mystery is how to balance innovation on a fresh platform built from scratch with the legacy tech stack, product suite and customers that continue to serve as the business' foundation. In his General Session at 19th Cloud Expo, Michael Chambliss, Head of Engineering at ReadyTalk, discussed why and how ReadyTalk diverted from healthy revenue and mor...
Information technology is an industry that has always experienced change, and the dramatic change sweeping across the industry today could not be truthfully described as the first time we've seen such widespread change impacting customer investments. However, the rate of the change, and the potential outcomes from today's digital transformation has the distinct potential to separate the industry into two camps: Organizations that see the change coming, embrace it, and successful leverage it; and...
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
You have great SaaS business app ideas. You want to turn your idea quickly into a functional and engaging proof of concept. You need to be able to modify it to meet customers' needs, and you need to deliver a complete and secure SaaS application. How could you achieve all the above and yet avoid unforeseen IT requirements that add unnecessary cost and complexity? You also want your app to be responsive in any device at any time. In his session at 19th Cloud Expo, Mark Allen, General Manager of...
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
Cloud Expo, Inc. has announced today that Andi Mann returns to 'DevOps at Cloud Expo 2017' as Conference Chair The @DevOpsSummit at Cloud Expo will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "DevOps is set to be one of the most profound disruptions to hit IT in decades," said Andi Mann. "It is a natural extension of cloud computing, and I have seen both firsthand and in independent research the fantastic results DevOps delivers. So I am excited to help the great t...
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain. In this power panel at @...
Bert Loomis was a visionary. This general session will highlight how Bert Loomis and people like him inspire us to build great things with small inventions. In their general session at 19th Cloud Expo, Harold Hannon, Architect at IBM Bluemix, and Michael O'Neill, Strategic Business Development at Nvidia, discussed the accelerating pace of AI development and how IBM Cloud and NVIDIA are partnering to bring AI capabilities to "every day," on-demand. They also reviewed two "free infrastructure" pr...
Financial Technology has become a topic of intense interest throughout the cloud developer and enterprise IT communities. Accordingly, attendees at the upcoming 20th Cloud Expo at the Javits Center in New York, June 6-8, 2017, will find fresh new content in a new track called FinTech.
Get deep visibility into the performance of your databases and expert advice for performance optimization and tuning. You can't get application performance without database performance. Give everyone on the team a comprehensive view of how every aspect of the system affects performance across SQL database operations, host server and OS, virtualization resources and storage I/O. Quickly find bottlenecks and troubleshoot complex problems.